Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea
· Delayed Price · Currency is KRW 293.00
+2.00 (0.69%)
At close: Dec 5, 2025
Abpro Bio Revenue
Abpro Bio had revenue of 7.87B KRW in the quarter ending September 30, 2025, a decrease of -40.72%. This brings the company's revenue in the last twelve months to 36.18B, up 31.98% year-over-year. In the year 2024, Abpro Bio had annual revenue of 31.66B with 24.78% growth.
Revenue (ttm)
36.18B
Revenue Growth
+31.98%
P/S Ratio
2.31
Revenue / Employee
822.33M
Employees
44
Market Cap
83.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.66B | 6.29B | 24.78% |
| Dec 31, 2023 | 25.38B | 3.26B | 14.76% |
| Dec 31, 2022 | 22.11B | -10.80B | -32.82% |
| Dec 31, 2021 | 32.91B | -2.88B | -8.05% |
| Dec 31, 2020 | 35.80B | 3.87B | 12.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |
| KB Financial Group | 14.89T |